K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratificationAndrew S. Levey, Antonio M. Gotto, Josef Coresh et al.|Data Archiving and Networked Services (DANS)|2002Cited by 11.7k
GFR Decline as an End Point for Clinical Trials in CKD: A Scientific Workshop Sponsored by the National Kidney Foundation and the US Food and Drug AdministrationAndrew S. Levey, Josef Coresh, Lesley A. Inker et al.|American Journal of Kidney Diseases|2014Cited by 597
Change in Albuminuria and GFR as End Points for Clinical Trials in Early Stages of CKD: A Scientific Workshop Sponsored by the National Kidney Foundation in Collaboration With the US Food and Drug Administration and European Medicines AgencyAndrew S. Levey, Kerry Willis, Tom Greene et al.|American Journal of Kidney Diseases|2019Cited by 561